Patents by Inventor MARIE-LUISE BERNASCONI

MARIE-LUISE BERNASCONI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES BINDING TO GPRC5D
    Publication number: 20240067749
    Abstract: The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
    Type: Application
    Filed: April 28, 2023
    Publication date: February 29, 2024
    Inventors: GEORG FERTIG, CHRISTIAN KLEIN, STEFAN LORENZ, WEI XU, MARIE-LUISE BERNASCONI, ALEXANDER BUJOTZEK
  • ANTIBODIES BINDING TO GPRC5D
    Publication number: 20230212308
    Abstract: The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
    Type: Application
    Filed: September 23, 2022
    Publication date: July 6, 2023
    Inventors: Georg FERTIG, Christian Klein, Stefan Lorenz, Wei Xu, Marie-Luise Bernasconi, Alexander Bujotzek
  • ANTIBODIES BINDING TO GPRC5D
    Publication number: 20220411491
    Abstract: The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
    Type: Application
    Filed: January 28, 2022
    Publication date: December 29, 2022
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Marie-Luise BERNASCONI, Georg FERTIG, Christian KLEIN, Stefan LORENZ, Wei XU
  • ANTIBODIES BINDING TO GPRC5D
    Publication number: 20210054094
    Abstract: The present invention generally relates to antibodies that bind to GPRC5D, including bispecific antigen binding molecules e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
    Type: Application
    Filed: July 31, 2020
    Publication date: February 25, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: GEORG FERTIG, CHRISTIAN KLEIN, STEFAN LORENZ, WEI XU, MARIE-LUISE BERNASCONI, ALEXANDER BUJOTZEK